Rigel Pharma (RIGL) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.60 +0.09%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
CRMT, PKE, HELE, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $16.74 million versus the consensus estimate of $17.54 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
